Wilson Sonsini Goodrich & Rosati advised Spark I Acquisition Corp. on the offering, and Ellenoff Grossman & Schole advised Cantor Fitzgerald & Co. Spark I Acquisition...
Spark I Acquisition Corporation’s $100 Million Initial Public Offering
Cleanlab’s $25 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Cleanlab on the transaction. Cleanlab announced it closed $25 million in a Series A financing round co-led by Menlo Ventures and...
Nextdata’s $12 Million Seed Financing Round
Wilson Sonsini Goodrich & Rosati advised Nextdata on the transaction. Nextdata announced it has raised a total of $12 million in seed investment, led by Greycroft and Acrew Capital, with participation...
Iambic Therapeutics’ $100 Million Series B Financing Round
Wilson Sonsini Goodrich & Rosati advised Iambic on the transaction. Iambic Therapeutics announced the closing of an oversubscribed $100 million Series B financing. The round was co-led by...
Synqly’s $4 Million Seed Financing Round
Wilson Sonsini Goodrich & Rosati advised Synqly on the transaction. Synqly, Inc. announced it emerged from stealth and raised $4 million in seed funding from SYN Ventures,...
JURA Bio’s $16.1 Million Financing and Replay Collaboration
Wilson Sonsini Goodrich & Rosati advised JURA Bio on both the financing transaction and the collaboration agreement. JURA Bio announced a research collaboration with Syena, a cell...
Avalyn Pharma’s $175 Million Series C Financing Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings A/S and Vida Ventures on the transaction. Avalyn Pharma Inc. announced the closing of an oversubscribed $175 million...
ZX Inc.’s HK$266 Million Hong Kong IPO
Kirkland & Ellis, Beijing Dacheng Law Offices, LLP, Goldsun Law Firm and Walkers (Hong Kong) represented ZX Inc., and Wilson Sonsini Goodrich & Rosati and JunHe...
Azurity Pharmaceuticals’ Acquisition of Slayback Pharma
White & Case and Wilson Sonsini Goodrich & Rosati advised Azurity Pharmaceuticals, Inc., and Kirkland & Ellis advised Slayback Pharma LLC on the transaction. Azurity Pharmaceuticals,...
Adela’s $48 Million Financing Round
Wilson Sonsini Goodrich & Rosati advised Adela on patent matters related to the transaction. Adela, Inc. announced the completion of a $48 million financing. The round included existing...
Amazon’s $4 Billion Partnership with Anthropic
Wilson Sonsini Goodrich & Rosati represented Anthropic in the commercial aspects of the transaction. Amazon announced its investment up to $4 billion into Anthropic, an AI developer known...
Cyclo Therapeutics’ Acquisition of Applied Molecular Transport
Fox Rothschild LLP is acting as legal advisor to Cyclo Therapeutics and Wilson Sonsini Goodrich & Rosati, P.C. is acting as legal advisor to Applied Molecular...